Dr. Brenda Raud
Dr. Brenda Raud is a postdoctoral researcher in the Division of Molecular Oncology and Immunology at the Netherlands Cancer Institute, in Amsterdam. She studied biotechnology in Argentina and later received her Ph.D. in Immunology from the Hannover Medical School in Germany. During her doctorate, she characterized the metabolism of T cells and the mechanisms by which metabolic pathways can shape the immune response to health and disease. Dr. Raud is currently researching the role of lymphocytes in the immune response against cancer and developing therapies that harness the power of T cells to treat a range of solid tumors. Besides being passionate about science and the intricacies of the immune system, Dr. Raud is an enthusiastic ex-pat: she has lived in three countries, done research in five, and is keen on picking up languages along the way.
Dr. Jason Goldsmith
Jason Goldsmith is Senior Director of Donor Medical and Analytical Sciences at Seres Therapeutics, a biotechnology company working to revolutionize the treatment of a wide range of diseases by modulating the function of the human microbiome. He was previously a postdoctoral researcher at the University of Pennsylvania’s Institute for Immunology, where he studied the intersection of intestinal regeneration, intestinal immunity, and host-microbiome interactions with the goal of one day being able to control intestinal regeneration therapeutically, both to enhance it during inflammatory processes (such as Colitis, Crohn’s, or radiation-induced enteropathy) or selectively inhibit it in colorectal cancer. He completed 2 years of internal medicine residency at the University of Michigan before deciding to focus on a research career and still works part-time as a hospitalist. Jason used to be a professional martial arts instructor and still trains in his free time. He also enjoys role-playing games and the occasional video game.